Bharat Biotech (BB) founder and chairman Dr Krishna Ella, on Monday, said that the approval for BB’s Covaxin was being dragged into a political controversy and that it was within the rules laid down by the government in 201
Coronavirus: In such a scenario — absent drugs and vaccines — non-pharmacological measures like hygiene, distancing and wearing masks have the most efficacy.
The way to test the entire country is to do the kind of antibody tests or sero-surveys that ICMR did last month regularly to see which parts of the country are more likely to have a higher disease burden.
An RT-PCR test takes several hours for the result to be available. We cannot make a patient who comes with a non-Covid-19 problem wait till that result is available.
It is difficult to comment on a trend—the only thing that can be said with some degree of certainty is that asymptomatics are largely below 50-45 years of age.
Reddy spoke of how it is very difficult to catch asymptomatics, unless individuals get themselves tested on demand, or the public health authorities organise testing in a cluster.
CDDEP-Princeton-Johns Hopkins researchers estimate a mammoth hospitalisation problem from COVID-19 in India. Pushing out the peak,i.e. delaying its occurrence through lockdowns, seems the only workable strategy till a vaccine
The 30th reported case is considered for the baseline since the growth in cases since the first reported case/clutch of cases has seen widely varying timelines.
In either case, the study shows more testing as well as thorough mapping an investigation of contacts is required for a complete picture of the spread of the infection.
A study by two India-origin researchers at the University of Cambridge, is based on the SIR approach, but takes into account age and social contact structure to assess the impact of the lockdown and social distancing measures
The report, based on the lockdowns in effect in the country at the time of its drafting, estimates ~190 million infected at the peak of the Covid 19 outbreak in the country.
The ICMR has prioritised urgent delivery of the new kits, asking potential suppliers to state the maximum supply capability for the first week, at six locations.
Lopinavir/Ritonavir, a fixed dose combination antiretroviral sold under the brand name of Kaletra, has been approved by the Central Drugs Standard Control Organization (CDSCO), for restricted public health use among the sympt
The Trump impeachment trial shows up the basket of deplorables the Senate Republicans showed themselves as willing to become to keep the Trump circus running even as the fundamentals of America’s liberal democracy are bulld